Microenvironmental regulation of BRCA1 gene expression by c-Jun and Fra2 in premalignant human ovarian surface epithelial cells

Molecular Cancer Research

Volumn 11, Issue 3, 2013, Pages 272-281

  Zhou, Lixin ^a   Graves, Marcia ^a   MacDonald, Gwen ^c   Cipollone, Jane ^a   Mueller, Christopher R ^b   Roskelley, Calvin D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN C JUN; TRANSCRIPTION FACTOR FRA 2;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EPITHELIUM CELL; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY CARCINOMA; OVARY CELL; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; STEADY STATE; SUSPENSION CELL CULTURE; TRANSCRIPTION INITIATION; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

BRCA1 PROTEIN; CELL LINE, TUMOR; EPITHELIAL CELLS; FEMALE; FOS-RELATED ANTIGEN-2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARY; TRANSCRIPTION FACTORS; TUMOR MICROENVIRONMENT;

EID: 84875474617     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-12-0395     Document Type: Article

References (39)

1. Vergote I, Trope CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. J Engl J Med 2010;363:943-53.
2. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609-614.
3. Graves ML, Zhou L, MacDonald G, Mueller CR, Roskelley CD. Regulation of the BRCA1 promoter in ovarian surface epithelial cells and ovarian carcinoma cells. FEBS Lett 2007;581:1825-33. (Pubitemid 46602276)
4. Suen TC, Goss PE. Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 bi-directional promoter. J Biol Chem 1999;274:31297-304.
5. Thakur S, Croce CM. Positive regulation of the BRCA1 promoter. J Biol Chem 1999;274:8837-43. (Pubitemid 29164683)
6. Atlas E, Stramwasser M, Whiskin K, Mueller CR. GA-binding protein alpha/beta is a critical regulator of the BRCA1 promoter. Oncogene 2000;19:1933-40. (Pubitemid 30219036)
7. Atlas E, Stramwasser M, Mueller CR. A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element. Oncogene 2001;20:7110-14. (Pubitemid 33052204)
8. Suen TC, Tang MS, Goss PE. Model of transcriptional regulation of the BRCA1-NBR2 bi-directional transcriptional unit. Biochim Biohys Acta 2005;1728:126-34. (Pubitemid 40602156)
9. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001; 22:255-88. (Pubitemid 32458162)
10. Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.AmJ Surg Pathol 2010;34:433-43.
11. Jarboe E, Folkins A, Nucci MR, Kindelberger D, Drapkin R, Miron A, et al. Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol 2008;27:1-9. (Pubitemid 351627965)
12. Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, et al. Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls. Gynecol Oncol 2012;127:88-93.
13. Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 2007;25:3985-90. (Pubitemid 47477278)
14. O'Connell FC, Martin F. Laminin-rich extracellular matrix association with mammary epithelial cells suppresses Brca1 expression. Cell Death Differ 2000;7:360-67. (Pubitemid 30209663)
15. Murtagh J, McArdle E, Gilligan E, Thornton L, Furlon F, Martin F. Organization of mammary epithelial cells into 3F acinar structures requires glucocorticoid and JNK signaling. J Cell Biol 2004;166:133-43. (Pubitemid 38931923)
16. Maines-Bandiera SL, Kruk PA, Auersperg N. Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am J Obstet Gynecol 1992;167:729-35.
17. Wu C, Cipollone J, Maines-Bandiera S, Tan C, Karsan A, Auersperg N, et al. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian formation and progression. Differentiation 2008;76:193-205. (Pubitemid 351197172)
18. Roskelley CD, Desprez PY, Bissell MJ. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc Natl Acad Sci U S A 1994;91:12378-82.
19. Thakur S, Nakamura T, Calin G, Russo A, Tamburrino JF, Shimizu M, et al. Regulation of BRCA1 transcription by specific single-stranded DNA binding factors. Mol Cell Biol 2003;23:3774-87. (Pubitemid 36597458)
20. Udalova IA, Kwiatkowski D. Interation of AP-1 with a cluster of NF-kappa B binding elements in the human TNF promoter region. Biochem Biophys Res Commun 2001;289:25-33. (Pubitemid 33108786)
21. Olive M, Krylov D, Echlin DR, Gardner K, Taparowsky E, Vinson C. A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J Biol Chem 1997;272:18586-94. (Pubitemid 27318198)
22. MacDonald G, Stramwasser M, Mueller CR. Characterization of a negative transcriptional element in the BRCA1 promoter. Breast Cancer Res 2007;9:R49.
23. Bindra RS, Gibson SL, Meng A, Westermark U, Jasin M, Pierce AJ, et al. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res 2005;65:11597-604. (Pubitemid 41821719)
24. Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR, Skubitz AP. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol Oncol 2004;93:170-181. (Pubitemid 38429567)
25. Mammoto A, Ingber DE. Cytoskeletal control of growth and cell fate switching. Curr Opin Cell Biol 2009;21:864-70.
26. Flam F, Einhorn N, Sjovall K. Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1988;27:53-7.
27. Davidson B, Risberg B, Reich R, Berner A. Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis. Clin Lab Med 2003;23:729-54. (Pubitemid 37175552)
28. Levanon K, Crum C, Drapkin R. New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 2008;26:5284-93.
29. Miralem T, Avraham HK. Extracellular matrix enhances heregulindependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus. Mol Cell Biol 2003;23:579-93. (Pubitemid 36050551)
30. Antonova L, Mueller CR. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer. Genes Chromosome Cancer 2008;47:341-52. (Pubitemid 351323764)
31. McMillen BD, Aponte MM, Liu Z, Helenowski IB, Scholtens DM, Buttin BM, et al. Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma. Mod Pathol 2012;25:1644-53.
32. Orr AW, Helmke BP, Blackman BR, Schwartz MA. Mechanisms of mechanotransduction Dev. Cell 2006;10:11-20.
33. Provenzno PP, Keely PJ. Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J Cell Sci 2011;124:1195-1205.
34. Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, et al. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Caner Res 2000;60:5329-33.
35. Wilcox CB, Baysal BE, Gallion HH, Strange MA, Deloia JA. Highresolution methylation analysis of the BRCA1 promoter in ovarian tumors. Cancer Genet Cytogenet 2005;159:114-22. (Pubitemid 40719379)
36. Chiang JW, Karlan BY, Cass L, Baldwin RL. BRCA1 promoter methylation predicts adverse ovarian cancer prognosis. Gynecol Oncol 2006;101:403-10. (Pubitemid 43729975)
37. DiNardo DN, Butcher DT, Robinson DP, Archer TK, Rodenhiser DI. Functional analysis ofCpG methylation in the BRCA1 promoter region. Oncogene 2001;20:5331-40. (Pubitemid 32844064)
38. Baylin S, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 2011;11:726-34.
39. Zhang Y, Shu J, Si J, Shen L, Estecio MRH, Issa J-PJ. Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island. Nuclei Acid Res 2012;40:7257-68.